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ABSTRACT  
The adverse outcome pathway (AOP) framework provides an alternative to traditional in vivo 
experiments for the risk assessment of chemicals.  AOPs consist of a number of key events 
(KEs) linked by key event relationships (KERs) across a range of biological organization backed 
by scientific evidence. The first KE in the pathway is the molecular initiating event (MIE); the 
initial chemical trigger that starts an AOP. Over the last three years the AOP conceptual 
framework has gained a large amount of momentum in toxicology as an alternative to animal 
methods and so the MIE has come into the spotlight. What is an MIE? How can MIEs be 
measured or predicted?  What research is currently contributing to our understanding of MIEs? 
With this review we outline answers to these key questions. 
 
INTRODUCTION 
Toxicology risk assessment is undergoing a paradigm shift away from in vivo data and towards 
risk assessment frameworks that incorporate non-animal alternatives. Traditional in vivo toxicity 
studies form the basis of the majority of regulations globally that relate to assuring human and 
environmental safety. Increasingly however, there are societal, scientific and regulatory drivers 
to develop new ways of assuring safety that do not rely on data generation in animals. Rather 
than relying on apical toxicity endpoints in animals, new frameworks rely on an understanding of 
the mechanism of a chemical’s toxicity in a relevant system which is thought to provide a more 
scientifically sound methodology on which to base risk assessment decisions. 
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The National Research Council of the United States (NRC) opened the field for discussion in 
2007, in an attempt to make toxicity testing quicker, less expensive, and more relevant to human 
exposures.
1
 It pointed to a number of advances in the fields of biology and biotechnology that 
make it possible to feed data into new risk assessment approaches. These include physiologically 
based pharmacokinetic (PBPK) modelling methods, which provide a better understanding of how 
a compound behaves inside the body, and how much of it is able to get to a site of action.
2,3
 
Furthermore, additional understanding of biological processes and the holistic nature of biology 
are being gained through -omics technologies
4–6
 and systems biology.
7,8
 In silico methods also 
have their part to play in this paradigm shift. Informatics approaches such as (Quantitative) 
Structure Activity Relationships ((Q)SARs) and Read-Across have the potential to make better 
use of existing data and target required testing to bring down the volume of in vivo studies 
required for a risk assessment.
9,10
 In addition to these, the coordination of the international 
scientific community, including collaboration between industry, academia and regulators, is of 
great importance for the advance of toxicity testing.
11,12
 These combined changes move 
toxicology away from a predominantly observational craft towards a science based on 
understanding.
13
 
The adverse outcome pathway (AOP) framework for risk assessment is one approach to combine 
in silico, in vitro and in chemico methods with existing data to offer an alternative to animal 
experiments. Since it was first described in 2010, this framework has gained a lot of attention 
within the toxicology community. The Molecular Initiating Event (MIE) is the initial chemical-
biological interaction that starts the AOP. Understanding, characterizing and predicting MIEs 
will be of great importance to allow the AOP framework to realize its potential as a predictive 
tool and this key interaction is the focus of this work. With this review we aim to cover key MIE 
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research between the description of the AOP framework in 2010 and the end of 2015, giving an 
overview of how this concept has risen to prominence, and how it will aid toxicity risk 
assessment of the future. 
This review is focused on the MIE within human health risk assessment, but MIEs are also 
relevant to ecotoxicology. Many of the ideas presented are equally applicable to ecotoxicology 
and human health, as the MIE occurs early in the AOP and can be common to a number of 
species. 
Up to 2012 
The first mention of a Molecular Initiating Event can be traced back to 2006. Schultz et al 
identified plausible MIEs based on the covalent interaction of soft electrophiles and biological 
molecules.
14
 These interactions can lead to a number of toxicological endpoints including skin 
sensitization, DNA damage and immunological responses. These MIEs are considered 
appropriate targets for (Q)SAR modeling, and some models are presented linking molecular 
reactivity at a thiol moiety to aquatic toxicity and respiratory irritation endpoints. These 
reactivity-driven MIEs and their subsequent toxicity pathways were a key driver for the 
development of the AOP framework. 
The modelling of chemical interactions between electrophiles and biological macromolecules 
was already established before the MIE. Work by Aptula and Roberts defined mechanistic 
domains for reactive aquatic toxicants,
15
 and the same mechanistic domains were later applied to 
skin sensitizers.
16
 This work due to a similarity in the MIE for these toxicological endpoints, the 
covalent modification of proteins. This MIE can be broken down based on the type of 
electrophilic chemistry that causes it. These categories were used as a basis for qualitative 
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mechanistic modelling (QMM), a type of local model based on linking toxic effects to 
physicochemical properties for a specific case rather than a global QSAR model encompassing a 
number of different reactivity domains and MIEs. These QMMs bring a transparent mechanistic 
basis to modelling, and a number have been developed since for different mechanistic categories 
leading to skin sensitization.
17
 These models, based on the interpretation of mechanistic 
chemistry, can be thought of as the precursor to the MIE. 
The AOP framework was first outlined by Ankley et al in 2010.
18
 Ankley presented the AOP as 
a conceptual framework, containing key information outlining the links between an MIE and an 
Adverse Outcome (AO) at a high level of biological organization relevant to risk assessment. 
Generalized examples of Key Events (KEs) along an AOP were presented by Ankley, including 
receptor/ligand interactions, DNA binding and protein oxidation. This conceptual framework is 
shown in Figure 1. 
A number of case examples from ecotoxicology were also presented, including pathways for 
narcosis, photo-activated toxicity, the aryl-hydrocarbon receptor, activation of the estrogen 
receptor and impaired vitellogenesis. It was noted that a complete AOP with full elucidation of 
all steps is not necessary for the AOP to be a useful tool. Gaps in an AOP can be filled using 
weight-of-evidence or statistical approaches to establish links between exposure and adverse 
outcomes. Much effort can be saved by specifically targeting areas of the AOP designated as 
important for the assessment of a specific endpoint. The AOP framework for risk assessment 
complies with the NRC's vision for the future of toxicity testing, allowing for the identification 
of specific endpoints of regulatory concern and providing understanding of the toxicity 
mechanisms that cause them.  
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This initial framework was extended by Villeneuve and Garcia-Reyero early in 2011,
19
 who 
identified the importance of predictive methodology in the application of AOPs. MIEs are 
critical interactions that can be modelled to develop (Q)SARs for predicting the likelihood of a 
chemical interacting with a specific target. In an analogous manner the AOP highlights key 
toxicity pathway events that can be linked to in vitro tests, and so can be used to predict or test a 
pathway. These enable the AOP framework to build upon previous risk assessment approaches, 
as well as to bring new science to bear on the problems and challenges faced by toxicology. 
The European funded initiative SEURAT-1
20
 started in January 2011, with the aim of developing 
a replacement for repeat-dose, systemic-toxicity in vivo tests. The strategy was to combine the 
use of in vitro and in silico methodologies, through a number of linked projects, to deliver results 
applicable in both the pharmaceutical, and consumer goods/cosmetics spheres. Of the seven 
projects, the most relevant to MIEs are COSMOS
21
 and ToxBank
22
. COSMOS is focused on the 
development of in silico open access tools for the prediction of systemic toxicity endpoints for 
cosmetic products. The ToxBank project is developing a web-based warehouse for systemic 
toxicity data, a database and repository for test compounds, and tissue and cell banks for in vitro 
tests. 
A first approach at linking the MIE to chemistry came from Enoch et al in 2011.
23
 Enoch related 
the MIE to chemical category formation, using the fact that genotoxic chemicals are often 
electrophilically reactive, leading to the covalent modification of DNA. A number of mechanistic 
categories were developed to describe such MIEs, including acylation, Michael addition, Schiff 
base formation, SN1, SN2, and SNAr. For each category, mechanistic and structural alerts were 
developed, combined into models know as in silico profilers, then assessed and discussed 
through a number of examples. Profilers such as these have been used to construct predictive 
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tools such as the OECD QSAR Toolbox.
24
 Enoch noted that, while the predictions made using 
these methods were only as good as the toxicological data that was sourced to build them, 
chemical categories are useful because they are mechanistically driven, and help to provide an 
understanding of why a chemical is able to undergo a specific interaction. This work aligns well 
with the MIE, as it too is mechanistically driven. This approach builds upon earlier work linking 
electrophilic reactivity to human health endpoints and brings it into an MIE perspective. 
Originally, an electrophilic index was used to predict skin sensitization potential quantitatively 
using Read-Across QSAR techniques.
25
 This was followed by the formation of electrophilic 
chemical groups for low molecular weight chemical compounds known to cause respiratory 
sensitization,
26
 and these rules were later developed to link respiratory sensitization mechanisms 
to the electrophilic index.
27
 These studies were published before the introduction of the MIE and 
AOP framework, but fit well with the ideas presented since, and conform to similar ideals. 
A key step in defining the AOP, and terms used within it, came from the OECD in 2012, 
28
 when 
it collected relevant definitions of important terms from the AOP and toxicity pathway research 
frameworks. The OECD defined the AOP as a linear sequence of events from the exposure of an 
individual to a chemical substance through to an understanding of the adverse (toxic) effect at 
the individual level (for human health) or population level (for ecotoxicological endpoints). An 
AOP consists of a number of KEs that are intermediate between the MIE and an apical adverse 
outcome. These KEs must be toxicologically relevant to the apical outcome and experimentally 
quantifiable. A number of similar, but distinctly different, definitions for the MIE were presented 
by the OECD, including: 
• The initial point of chemical-biological interaction within the organism that starts the 
pathway.
29
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• Direct interaction of a chemical with specific biomolecules.
19
 
• The molecular level, chemical-induced perturbation of a biological system. 
• Chemical interaction at a molecular target leading to a particular adverse outcome. 
• The seminal interaction (e.g. DNA-binding, protein oxidation, or receptor/ligand 
interaction) of a chemical with a biological target. 
The OECD recognized that the development and elucidation of AOPs will require contributions 
of multiple scientific fields, covering chemistry, biology and toxicology. Standardization of 
terms used in AOPs is necessary to allow these fields to communicate and develop the 
framework into the future. 
Developments in 2013 
In March 2013, the 7th amendment to the cosmetics directive 76/7678/EEC,
30
 and subsequent 
cosmetics regulation 1223/2009
31
 came into effect in Europe, enacting a ban on the use of animal 
testing for cosmetic ingredients. At this time, the availability of alternatives to in vivo methods 
appropriate for cosmetic product risk assessment varied greatly by endpoint. The commission 
noted that good progress had been made in the area of in vitro alternatives to measure basal 
cytotoxicity.
32
 In other areas, such as eye irritation and skin sensitization, more work is required 
to provide adequate alternatives. This important milestone, in the transition from toxicology 
dominated by in vivo methods to one accepting the non-animal alternatives of in vitro, in silico 
and in chemico, provides a key industrial incentive to the development of these alternatives, 
including the MIE and AOP. 
In a study analogous to an MIE approach to carcinogenicity, Benigni et al reviewed and 
combined a number of 2D SARs.
33
 Carcinogenicity is broken down by mechanism of action to 
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yield structural alerts for receptor binding, oxidative stress, hormonal imbalance, and direct and 
indirect alkylation of DNA. Of nine structural alert classes across genotoxic and non-genotoxic 
carcinogens, a positive predictivity of greater than 70% was obtained in six cases. This 
computational methodology shows the promise of the integration of theoretical knowledge with 
in vitro assay information. Benigni notes that the addition of further structural alerts will allow 
for an expansion of this approach, increasing its impact. 
Casalegno and Sello published a similar study predicting mode of action of environmental 
toxicants by structural similarity.
34
 These models were based not on experimental data, but on 
structural features alone. This approach relies on the fact that the interaction between well-
characterized molecules and an ill-defined biological target depends on the chemistry of both 
parts. Casalegno and Sello note that a lack of understanding of the modes of action associated 
with ecotoxicology makes this a difficult study, as poorly defined modes of action, such as 
narcosis or electrophilicity, are often used. Both a better understanding of the complex 
mechanisms behind ecotoxicity and a greater availability of data are required to make an 
approach such as this practically useful.  
Gutsell and Russell's 2013 analysis, 
35
 shows that chemistry is key to understanding the MIE and 
also has other important roles to play in the AOP framework. Linking a defined dose of a 
chemical compound to an adverse effect requires the use of both chemical information, including 
analytical experiments, and theoretical techniques, such as (Q)SARs. An understanding of the 
chemical attributes that are required to generate an MIE can be used to filter the number of 
pathways that need to be considered in risk assessment. The MIE can be boiled down to a 
chemical interaction, and so a series of in chemico experiments coupled with in silico models 
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will be able to make risk assessment, based on chemistry alone, a reality. A visualization of this 
wet/dry cycle is shown in Figure 2. 
AOP approaches were reviewed in mid-2013 by Vinken.
36
 This review covered the development 
of AOPs from key building blocks, and several well-developed examples were discussed, 
including skin sensitization, cholestasis, liver fibrosis and liver steatosis. Vinken also discussed 
the key roles of (Q)SARs and in vitro tests to predict and to inform pathways. Key challenges in 
the field are presented, including compliance with the complexity of toxicology, the inclusion of 
dose-response relationships in pathway development, the integration of exposure and 
toxicokinetic data, and the transparent and objective evaluation of the outcomes. 
Martin et al presented the use of mode of action to categorize aquatic toxicants and build 
models.
37
 This study involved modes of action including receptor agonism, enzyme inhibition, 
chemical reactivity and biosystem disturbance. Martin notes that while the models provide 
promising results (overall prediction accuracy 85%), further categorization of the more general 
modes of action, such as chemical reactivity, into smaller structural-mechanism groupings (as 
may be expected with a more MIE-like analysis) should improve predictivity. 
A key issue, particularly in ecotoxicology, is the extrapolation of data points between species 
during chemical risk assessment. This also applies to KEs within the AOP – including the MIE. 
LaLone et al described a quantitative tool for the extrapolation of MIEs between species using 
bioinformatics approaches and an understanding of the target species biology.
38
 The conservation 
of KEs across several AOPs is an important simplification of biology within the AOP approach. 
If some of these KEs can also be preserved across species, this will aid the difficult task of 
ecotoxicological risk assessment, due to the diverse nature of the environment, and provide 
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additional data points in human toxicology, where results can be read across from existing 
animal studies. 
An entirely quantitative risk assessment using the AOP framework was attempted by Maxwell et 
al at the end of 2013.
39
 The skin sensitization AOP was one of the first AOPs to be considered 
well developed within the field.
28
 Maxwell used KEs from early in the pathway to provide input 
parameters for the “total haptenated protein” model, with the “CD8+ T cell response” model 
providing predictions for KEs late in the pathway and for the overall adverse outcome (allergic 
contact dermatitis).  
Chemical dose applied to the skin is linked to the amount of total haptenated protein using 
mathematical models, taking into account the pharmacokinetic steps as the chemical travels from 
skin surface to the protein. These include clearance mechanisms, metabolism, and other chemical 
transformations. The CD8+ T cell response model aims to predict the number of hapten-specific 
human CD8+ central memory T cells generated following repeated exposure to a chemical 
sensitizer, using inputs from the total haptenated protein model. Maxwell suggests that, once a 
threshold of hapten-specific human CD8+ central memory T cells is exceeded, an inflammatory 
response will manifest upon re-exposure to a sensitizer. These models were at the time in the 
early stages of development. However, by benchmarking them against clinical data it should be 
possible to predict whether a specific skin exposure will cause the required hapten-specific T cell 
response required to cause an adverse effect upon re-exposure. 
In November 2013, Wu et al published a decision tree to predict Developmental And 
Reproductive Toxicity (DART) endpoints.
40
 This in silico assessment was made without use of 
an AOP framework and shows the complexity associated with predicting across multiple 
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endpoints and toxicity pathways. Development of the decision tree identified a number of 
important structural fragments that can enhance the understanding behind DART modes of 
action using MIEs. The decision tree itself allows for rapid screening of potential DART.  
Developments in 2014 
In January 2014, Caldwell et al published an integrated approach for prioritizing pharmaceutical 
ingredients for ecotoxicological risk assessment using an AOP-informed approach.
41
 Mammalian 
pharmacology data and pharmaceutical usage data were combined to provide a prioritization for 
risk assessment and advanced research. Prioritization of assessment is particularly important in 
ecotoxicology where the amount of data available to construct predictive models is often limited. 
In 2014 the AOP Wiki was released as version 1.0.
42
 This project represents a joint effort by the 
European Commission - Joint Research Centre and the U.S. Environmental Protection Agency, 
and serves as part of the OECD-sponsored AOP Knowledgebase. The AOP Wiki resource is 
designed to allow toxicology scientists to share AOP-related knowledge in an appropriate format 
in an open source forum. It also encourages the evaluation and acceptance of this research by the 
AOP community. The AOP Wiki represents an important tool in data-sharing and peer-review. 
Making research available through this wiki should be a priority for scientists working on AOPs 
and MIEs. 
Computationally linking the reactivity of a chemical compound to its skin sensitization potential 
has been a key goal of the AOP community as the skin sensitization AOP is one of the best 
developed within the AOP Wiki. The MIE for skin sensitization is the covalent modification of a 
skin protein by a toxicant. Building on their earlier work,
15–17
 Roberts and Aptula linked 
previously developed QMMs to local lymph node assay results for SNAr electrophiles in 2014.
43
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This resulted in the development of a linear relationship between reactivity parameters and EC3 
values measured experimentally. This analysis provides further evidence for the use of chemical 
reactivity as a descriptor for the analysis of the skin sensitization potential of novel molecules in 
the AOP framework.  
Modern approaches to toxicology risk assessment must attempt to improve on existing in vivo 
methods. Leist et al highlighted this in 2014, pointing out that limited resources and high cost 
associated with animal methods have led to a large number of chemicals being untested, and 
mixtures are rarely evaluated at all.
44
 Leist proposed a new vision, running chemicals and 
mixtures through in silico and in vitro approaches, using toxicity pathways, mode of action and 
AOP frameworks to gain a comprehensive evaluation. Only if no conclusive results can be 
obtained would animal testing be carried out. An understanding of the MIEs of these chemicals 
will aid in the generation of a comprehensive risk assessment of many chemicals without the use 
of in vivo experiments. A large number of under-tested chemicals and mixtures could be risk-
assessed using this high-throughput method, as illustrated in Figure 3. 
Molecular modelling is one area of in silico science that shows much promise in its ability to 
study the MIE. One such approach was published by Tsakovska et al in 2014.
45
 A model was 
developed for the PPARγ receptor as a target of interest for liver steatosis. The receptor binding 
pocket was analyzed using PPARγ complexes with full agonists from the Protein Data Bank 
(PDB),
46
 and a pharmacophore was developed encompassing the most important features for 
binding and their role in PPARγ activation. As may be expected for a receptor binding MIE, the 
pharmacophore consists of hydrogen bonding, hydrophobic and aromatic interactions between 
the ligand and PPARγ. Models such as this provide in silico screens to identify potential 
steatogenic inducers early in risk assessment. 
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Following their previous work into reactivity-driven MIEs for DNA modification,
23
 Nelms et al 
used a similar approach to develop a collection of structural alerts built into an in silico profiler 
for systemic toxicity of hair dyes.
47
 Repeat dose toxicity studies for 94 hair dyes were used, and 
chemicals were grouped based on structural similarity. Four categories were identified for hair 
dyes containing a 2-nitroaminobenzene, a 4-nitroaminobenzene, an aromatic azo, or an 
anthraquinone moiety. Nelms went on to develop a mechanistic hypothesis for each of the four 
groups, and refined structural alerts were presented as an in silico profiler, covering pro-
quinones, quinones, meta-substituted benzenes and aromatic azo compounds. This profiler 
assigned 56 of the 94 chemicals in the dataset to a mechanism-based chemical category. The 
reactivity-driven nature of these toxicity mechanisms may also allow the alerts to be used in 
mitochondrial toxicity, and this was also discussed by Nelms. This paper emphasizes that 
approaches like this do not attempt to predict oral repeat-dose toxicity, but instead a particular 
MIE that might be responsible for an AOP leading to chronic toxicity. Detailed studies such as 
this are required to develop models for MIEs, and to identify the MIEs themselves, as at this time 
they are generally poorly understood at a mechanistic level. 
The workshop “Advancing AOPs for Integrated Toxicology and Regulatory Applications” took 
place in 2014. One report from this workshop by Tollefsen et al mentions the pivotal role of 
MIEs.
48
 MIEs measured through in silico, in vitro and in chemico techniques were discussed and 
shown to have an important part to play in the AOP framework. MIEs cover a wide variety of 
chemical interactions, and these were highlighted through examples, including receptor binding 
MIEs leading to endocrine disruption and reproductive toxicity, as well as covalent binding to 
skin proteins leading to skin sensitization and allergic contact dermatitis, as has been discussed 
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above.
28
 These discussions highlight the significance of the MIE and the important roles different 
areas of toxicology will play in gaining an understanding of these key interactions. 
Chemistry’s key role in MIE and AOP research was further highlighted by Allen et al.
49
 AOP 
networks for a number of well-understood toxicants were developed using literature searches. 
These case studies were used to unify existing definitions of the MIE and concluded that an MIE 
is the initial interaction between a molecule and a biomolecule or biosystem that can be causally 
linked to an outcome via a pathway. The role of the MIE in AOP research and toxicity risk 
assessment was also discussed, including a framework in which an in silico (Q)SAR relates 
molecular properties of a novel compound to an MIE, and any associated AOP can then infer an 
expected adverse outcome for the compound, as shown in Figure 4. By establishing an 
understanding of the chemistry behind interactions between molecules and biomolecules or 
biosystems (Q)SARs can be constructed, allowing the MIE to directly contribute to toxicity 
screening processes and, later, with further quantitative understanding, risk assessments. 
Madden et al published a report on the development of AOPs in ecotoxicology in late 2014,
50
 
noting that AOPs can receive criticism due to their simplistic nature which makes them poor 
reflections of complex toxicological processes. In response, they point out that an AOP should 
never be seen as a complete picture, but as a flexible tool that will improve over time as new data 
is constantly added. Even if an AOP is incomplete, it can still provide a large amount of useful 
information in a risk assessment. In vitro to in vivo extrapolation (IVIVE) of doses also presents 
a challenge due to the difference between in vitro experiments and in vivo situations. For 
example in an in vitro assay does not consider the metabolism of a chemical. Effective 
integration of data from in chemico, in silico, in vitro and in vivo will be required to overcome 
this, and the AOP Wiki,
42
 among other resources,
22,24,51,52
 provides a way to achieve this. 
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As has already been discussed,
23,33,47
 structural alerts play a key part in predictive toxicology. 
Chemotypes were introduced in 2014 as a new way of coding such alerts, and Chemotyper is 
software that allows them to be searched against a dataset.
53
 Chemical substructure mark-up 
language (CSRML), an XML-based code, is used to capture chemotypes. This language allows 
for the inclusion of physico-chemical properties and descriptors as well as 2D structure, allowing 
greater flexibility of constructed models. 
Developments in 2015 
In February 2015, a report from FutureTox II (held in January 2014) was published by Knudsen 
et al
54
 The goals of this meeting were to discuss the progress towards the NRC's vision for 
toxicity testing in the 21st century
1
 and in silico and in vitro methodologies featured heavily. 
AOPs were discussed as a key concept. Despite OECD guidelines which state that an AOP links 
a single MIE and an effect at a high level of biological organization, it is accepted that a single 
MIE may lead to several AOPs and an adverse effect may be associated with several MIEs. AOP 
networks can capture the complexity of the biological sphere far better; and the MIE is identified 
as an important KE that can be used to screen compounds to identify the AOPs that are likely to 
be of most interest. 
The difficulty associated with IVIVE has already been mentioned.
50
 Angrish et al presented an 
approach to bridging the IVIVE gap in high throughput screening (HTS) assays.
55
 Using an 
ultra-sensitive gas-phase probe molecule, they aim to measure effects on metabolism that will 
link through to understood in vivo outcomes. As an example, the pharmacokinetic parameters 
associated with a cytochrome-2A6-driven metabolism were identified in order to measure the 
effect of a toxicant indirectly by observing a metabolite: methyl tertiary-butyl ether. 
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Methodology such as this allows MIEs and other KEs to be directly linked to relevant in vivo 
data. 
Steinmetz et al utilized open-source data to construct a screening tool for retinoic acid receptor 
binding using the MIE principle.
56
 2D fragments of binders were coded in SMARTS based on 
“rules” derived from the PDB. In addition to this, physicochemical properties (vertex adjacency 
information magnitude,
57
 number of rotational bonds, molecular weight and logarithm of the 
water-octanol partition coefficient) were used to give an insight into the physico-chemical 
applicability domain for retinoic acid receptor binding. These early approaches towards MIE 
tools are designed not to replace in vitro testing or be a complete in silico model, but rather to 
provide a rapid screen and prioritization methodology to assist in risk assessment. 
The importance and potential impact of AOPs as a framework in non-animal risk assessment was 
reviewed by Burden et al in March 2015.
58
 Key to the recent paradigm shift in toxicity testing is 
the Replacement, Refinement and Reduction of animal methods - also known as the 3Rs.
59
 The 
AOP framework provides an important scientific basis on which new risk assessment practices 
can be built - as no single alternative testing method will replace an in vivo model like-for-like. 
One such combined approach could involve the prediction of adverse effects based on a pre-
determined MIE. Concerted efforts to collect, integrate and organize data from relevant sources 
across scientific disciplines will be required to reap the benefits of such a coherent framework. 
Regulatory input is also required, to guide the use of AOPs in risk assessment decision-making.  
While single AOPs are considered the building blocks of AOP development, they are not a 
complete representation of complex biological systems when considered in isolation. AOP 
networks would seem to provide a solution to this, as described by Knapen et al. 
60
 AOPs are 
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constructed from MIEs, KEs and AOs that can be shared across multiple pathways. Where these 
common elements are shared, AOPs can be combined into AOP networks. This principle is 
demonstrated in the case of DART, where aryl hydrocarbon receptor, estrogen receptor, 
aromatase and androgen receptor-based MIEs lead to pathways that converge in DART 
endpoints. This AOP network is shown in Figure 5. The analysis of networks such as this 
conveys a number of advantages over considering AOPs in isolation. Not only are AOPs in 
isolation unrealistic, by combining them into networks of assays, measurement of a single MIE 
or KE can provide information on a number of different endpoints and pathways, improving 
testing efficiency. The more understanding that can be gained about the MIEs, KEs, and their 
networks the more potential combinations will come to light, further benefitting risk assessment. 
Judging the quality of AOPs will be an important step in their development to become a staple of 
the chemical risk assessment procedure. This is discussed by Becker et al who present a number 
of examples using the OECD approved Bradford-Hill considerations for the assessment of 
confidence in an AOP.
61
 These considerations include the biological plausibility and empirical 
evidence (i.e. dose-response) for KE relationships (KERs), and the essentiality of KEs (i.e. are 
downstream events prevented if an upstream event is blocked?). Each consideration is broken 
down, with the aim being to assign a high, moderate or low confidence in each KE or KER. 
Several case studies are given and the importance of using weight-of-evidence-based approaches 
to analyze AOPs discussed. To ensure transparency and promote consistency across AOP 
research, these kinds of confidence assessments must be carried out and analyzed. This 
ultimately will lead to enhanced rigor, transparency and reproducibility for AOP confidence 
assessment, improving confidence in AOPs themselves. 
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This particular area of AOP research has been further explored by Yauk et al
62
 The AOP for 
alkylation of DNA in male premeiotic germ cells leading to heritable mutations was examined in 
depth in order to establish its biological plausibility and the empirical evidence that supports it. 
In turn each KE was considered, examining how the KE works and how it was measured or 
detected experimentally. KERs are then examined, looking at how the biological processes work, 
the weight of evidence that supports them, any uncertainties or inconsistencies in their 
supporting data, and the level of quantitative understanding of the linkage they provide. 
Following this analysis the KEs and KERs are assessed as having strong, moderate, or low levels 
of confidence. A particular challenge, noted by Yauk, in this AOP development was the 
gathering of appropriate dose-response data for assessment of the Bradford-Hill considerations 
from historical studies that were not conducted with this type of research in mind and which are 
time-consuming to interpret. The AOP framework should be able to overcome this hurdle, since 
the more KEs and KERs are isolated, the more likely it is that new AOPs will incorporate KEs 
and KERs which have already been characterized, and so the process will speed up. 
Dent et al discussed the AOP for anti-androgenic activity in humans in a similar level of detail.
63
 
The aim was to establish the status of the tools and approaches being put towards a non-animal 
risk assessment for this AOP. A particular point noted here was the high level of uncertainty 
associated with the extrapolation of data from effects seen in high dose animal studies to the 
much lower exposures anticipated for humans. Therefore, the exposure of the human to the 
chemical will be key. If human exposure is not significant, is a detailed risk assessment 
necessary at all? 
Risk assessments for metals pose a number of different issues compared to those for organic 
chemicals. Von Stackelberg et al used an AOP approach to analyze the neurodegeneration 
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endpoint caused by the exposure of humans to metals and mixtures of metals, specifically lead, 
arsenic, cadmium and manganese.
64
 An AOP was developed and assessed using the Bradford-
Hill considerations. This AOP linked the activation of extracellular-signal-related kinase by 
metals to an increase in levels of cellular calcium ions and neurological disorders including 
deficits in learning and cognition. It is important that MIE and AOP approaches can be utilized 
in these different situations to increase their impact in toxicology. 
Following on from previous work into in silico models for reactivity driven MIEs for DNA 
modification
23
 and skin sensitisation
47
, Nelms et al published the development of an in silico 
profiler for analyzing mitochondrial toxicity in June 2015.
65
 Category formation based on 
structural similarity was performed on a set of pharmaceutical drugs with mitochondrial toxicity 
data. Once categories had been decided, a literature search was undertaken to elucidate 
mechanistic information behind the MIE, and other KEs in AOPs associated with mitochondrial 
disruption. Structural alerts were defined and coded in SMARTS using information from the 
literature and substructures from the category formation. The structural alerts highlight 
molecules that exhibit toxicity as protonophores, redox cyclers, and inhibitors of the complexes 
of the electron transport chain. With a small amount of data available, this study has been able to 
gain insight into several key MIEs for mitochondrial dysfunction, and provide a profiler that can 
be utilized to screen large data sets to identify chemicals with the potential to induce 
mitochondrial toxicity. 
A number of AOPs leading to hepatic toxicity were compiled by Mellor et al in late 2015.
66
 This 
work links the agonism and/or antagonism of several nuclear receptors to hepatic steatosis via a 
number of converging pathways. These pathways are currently reasonably well understood from 
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a biological standpoint, but further research is required to elucidate key information about the 
MIE and build structural alerts or other models to be able to predict this endpoint. 
Difficulty in understanding MIEs can be aided by finding new ways to measure them, and this 
was demonstrated by Sanderson et al using NMR spectroscopy.
67
 The binding of molecules to 
protein residues features in MIEs for skin sensitization and hepatotoxicity among others. The rate 
of this reaction could be used to inform toxicological risk assessments quantitatively, providing 
an in chemico link between molecule and extent of protein modification. NMR spectroscopy was 
used to measure these rates for the reactions of electrophilic organic chemicals (representing 
different mechanistic classes) and simple amines and thiols (representing lysine and cysteine 
protein side chains respectively). In chemico assays, such as this, will be important in informing 
MIE and AOP driven toxicological risk assessment, providing vital quantitative information and 
experimental validation. 
Constant development of new AOPs has led to the discovery and characterization of new MIEs, 
for example, the chemicals binding to tubulin identified by Marchetti et al in late 2015.
68
 This 
MIE leads to aneuploidy offspring – a teratogenic disorder causing an abnormal number of 
chromosomes. The majority of data for the MIE and KEs of this AOP come from rodent studies. 
They are thought to be conserved in humans, allowing the extrapolation of the existing in vivo 
data for use in human toxicology. Similarities in the mechanism of action across several phyla 
and the high homology between mouse and human tubulin provide evidence for this. This MIE 
presents an interesting case, in which in silico, in chemico, in vitro and in vivo studies may all be 
able to be used to predict the impact of an MIE in humans. 
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The main drive in the development of AOPs up to this point has been for the risk assessment of 
cosmetic products and industrial chemicals. AOPs can also find use in drug development, as was 
discussed by Patlewicz and Fitzpatrick in December 2015.
69
 They focused mainly on the use of 
in silico tools, particularly (Q)SARs, for the prediction of KEs along an AOP. While a number of 
tools, some of which we have already discussed, have been developed previously, the number of 
KEs requiring prediction will continue to demand more from (Q)SAR scientists. It is particularly 
highlighted that AOPs must be kept in mind during the development of new (Q)SARs, 
promoting the development of tools which model small steps between KEs and not large leaps 
over many complex levels of biological organization. 
At the end of 2015 the SEURAT-1 initiative closed and the EU-ToxRisk program,
70
 was initiated 
early in 2016 to continue driving mechanism-based toxicity testing for risk assessment in the 
21st century. 
CONCLUSIONS 
As toxicology moves away from animal experiments and towards in silico, in vitro and in 
chemico methods, as well as combinations of these, deeper understanding and new tools are 
required. The AOP framework provides a powerful method to do this. As arguably the most 
important key event within the AOP, a greater knowledge of MIEs will be vital to the success of 
this framework. A greater understanding of the MIE must be developed, and tools must be 
constructed to allow MIEs to be predicted, and measured for novel compounds. 
The MIE sits on the boundary between biology and chemistry, and as such both these fields have 
important roles to play in its development. This has been shown in this review, with a number of 
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publications coming from both a chemical and biological background. In silico, in vitro and in 
chemico methods all have a part to play, and this is also represented.  
As the first KE in an AOP, the MIE has a key role to play in the understanding of toxicity in both 
humans and animals. As a result the MIE is applicable in both human health and ecotoxicology 
risk assessment. The MIE and AOP provide a template for the coming together of these fields, as 
it is expected that some, but not all, of the KEs and KERs will be shared across species. One of 
the main drives of the AOP framework is for better risk assessment procedures, and this 
collaboration can help by providing additional data and understanding previously confined to 
their fields. 
As outlined above a number of MIEs have now been characterized. This allows us to begin 
grouping these interactions based on their chemistry. The earliest studied MIEs were covalent 
bond forming reactions between chemicals and biological molecules. These MIEs include the 
reactions of electrophilic chemicals with DNA molecules,
23
 and the covalent modification of 
skin proteins.
43
 MIEs such as these can lead to toxicological endpoints such as allergic contact 
dermatitis,
39
 genotoxicity, and immunological disorders.
39
 
A second category of MIEs is those which involve non-covalent binding of a chemical to a 
biological target such as a receptor or enzyme. These can include the activation of PPARγ,45 or 
the agonism or antagonism of nuclear receptors,
66
 both leading to liver steatosis, the inhibition 
of complexes of the mitochondrial electron transport chain leading to mitochondrial 
dysfunction,
65
 and the binding of chemicals to tubulin leading to teratogenic endpoints.
68
 
A final category of MIEs is for those chemicals that do not directly interact with a specific 
biomolecule, but rather cause a disturbance in cellular or organelle biosystems. Biosystem 
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disturbance has been alluded to in several cases
37,49
 and provides an MIE category for the 
narcosis mode of action often used in ecotoxicology which is associated with membrane 
disruption.
34
 Other biosystem disturbance MIEs include chemicals which act as protonophores or 
redox cyclers leading to mitochondrial toxicity endpoints.
65
 
The impact of the MIE and AOP framework has undoubtedly increased over the last three years, 
with the number of publications contributing to the area increasing each year. The understanding 
gained, and tools developed so far, represent an important platform for future development, with 
the ultimate aim being a tool for quantitatively predicting the impact of a chemical on a human 
or ecotoxicological target. The emergence of the MIE highlights the idea that chemical 
understanding is critical in modelling, and that mechanistic local modelling is key to providing 
the best predictions. Feeding an MIE prediction tool into a combined AOP framework, 
incorporating exposure, absorption, distribution, metabolism and excretion (ADME), and an 
understanding of downstream effects along the AOP will be able to provide a genuine alternative 
for toxicology: reliable risk assessment entirely free of in vivo experiments.  
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FIGURES  
 
Figure 1. Ankley’s conceptual diagram of an AOP, including the MIE (Anchor 1). Adapted with 
permission from Ankley, G. T., Bennett, R. S., Erickson, R. J., Hoff, D. J., Hornung, M. W., 
Johnson, R. D., Mount, D. R., Nichols, J. W., Russom, C. L., Schmieder, P. K., Serrrano, J. A., 
Tietge, J. E., and Villeneuve, D. L. (2010) Adverse outcome pathways: A conceptual framework 
to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem., Vol. 29, 730–
741,
18
 from John Wiley & Sons Inc. 
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Figure 2. A wet/dry cycle for the development of in silico models. Adapted from Gutsell, S., and 
Russell, P. (2013) The role of chemistry in developing understanding of adverse outcome 
pathways and their application in risk assessment. Toxicol. Res., Vol. 2, 299–307,
35
 with 
permission from The Royal Society of Chemistry.  
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Figure 3. Leist's new vision for the future of toxicity testing. Adapted with permission from 
Leist, M., Hasiwa, N., Rovida, C., Daneshian, M., Basketter, D., Kimber, I., Clewell, H., Gocht, 
T., Goldberg, A., Busquet, F., Rossi, A. M., Schwarz, M., Stephens, M., Taalman, R., Knudsen, 
T. B., McKim, J., Harris, G., Pamies, D., and Hartung, T. (2014) Consensus report on the future 
of animal-free systemic toxicity testing. ALTEX 31, 341–356.
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Figure 4. Framework for a (Q)SAR approach based around MIEs. The (Q)SAR relates 
molecular characteristics to the MIE and the AOP infers an adverse outcome from the MIE. 
Adapted from Allen, T. E. H., Goodman, J. M., Gutsell, S., and Russell, P. J. Defining Molecular 
Initiating Events in the Adverse Outcome Pathway framework for risk assessment. Chem. Res. 
Toxicol. 27, 2100–2112. Copyright 2014 American Chemical Society.
49
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Figure 5. An example of an AOP network based on five reproductive and developmental 
toxicity-related AOPs in fish available on the AOP wiki. MIEs are indicated in green, KEs in 
orange and adverse outcomes in red, as per the AOP wiki template. The grey box represents a 
KE with a “weak” weight of evidence. The dotted squares indicate KEs that are defined as 
changes in the opposite direction of the same biological component. AHR: aryl hydrocarbon 
receptor, E2: estradiol, GtH: gonadotrope hormone, T: testosterone, VTG: vitellogenin. 
Reprinted from Reproductive Toxicology, Vol. 56, Dries Knapen, Lucia Vergauwen, Daniel L. 
Villeneuve, Gerald T. Ankley; The potential AOP networks for reproductive and developmental 
toxicity assay development; pp 52-55; Copyright 2015;
60
 with permission from Elsevier. 
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